retatrutide clinical trial sign up UK: 2026 & Approval Guide – Trim Retatrutide Where to Get: Can

Lixisenatide also showed small but significant benefits for urinary albumin to creatinine ratio (24% vs 24% from baseline to month 24), weight loss (-0.7 kg) and blood pressure (-0.8 mm Hg)

Unlike approved agents such as semaglutide or tirzepatide, retatrutide's broader receptor activity particularly its glucagon component may produce a more pronounced chronotropic effect

Common side effects Nausea, especially in the first weeks and after a dose increase Mild constipation or diarrhea Reduced appetite and early fullness Occasional reflux and fatigue in the first weeks Most of these are dose-dependent and improve when we slow the titration pace or adjust how you eat

doi:10.1016/j.pharmthera.2012.07.006 18

Gautier, A

Strategies for repositioning and repurposing drugs using existing drugs for new therapeutic applications offer promising approaches to treating neurological and psychiatric diseases associated with insulin resistance and neurodegeneration